Huntington’s disease: Managing neuropsychiatric symptoms in Huntington’s disease

Samantha M. Loi; Mark Walterfang; Dennis Velakoulis; Jeffrey C.L. Looi

doi:10.1177/1039856218766120

Huntington’s disease: Managing neuropsychiatric symptoms in Huntington’s disease

Samantha M. Loi^*, Mark Walterfang, Dennis Velakoulis, Jeffrey C.L. Looi

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Abstract

Objectives: This clinical update review focuses on the management of the neuropsychiatric manifestations of Huntington’s disease (HD). The review highlights current issues regarding pharmacological and non-pharmacological treatment, putative therapeutics and recent relevant research findings in this area. Conclusions: Neuropsychiatric symptoms may precede the classic motor clinical symptoms of HD (prodromal HD) by decades and cause significant functional impairment. Early recognition and comprehensive non-pharmacological, usually in combination with pharmacological, treatment is essential.

Original language	English
Pages (from-to)	376-380
Number of pages	5
Journal	Australasian Psychiatry
Volume	26
Issue number	4
DOIs	https://doi.org/10.1177/1039856218766120
Publication status	Published - 1 Aug 2018

Access to Document

10.1177/1039856218766120

Cite this

@article{29c55e6492cf43caa3209622a4796d12,

title = "Huntington{\textquoteright}s disease: Managing neuropsychiatric symptoms in Huntington{\textquoteright}s disease",

abstract = "Objectives: This clinical update review focuses on the management of the neuropsychiatric manifestations of Huntington{\textquoteright}s disease (HD). The review highlights current issues regarding pharmacological and non-pharmacological treatment, putative therapeutics and recent relevant research findings in this area. Conclusions: Neuropsychiatric symptoms may precede the classic motor clinical symptoms of HD (prodromal HD) by decades and cause significant functional impairment. Early recognition and comprehensive non-pharmacological, usually in combination with pharmacological, treatment is essential.",

keywords = "huntington{\textquoteright}s disease, neuropsychiatric symptoms, psychiatry",

author = "Loi, \{Samantha M.\} and Mark Walterfang and Dennis Velakoulis and Looi, \{Jeffrey C.L.\}",

note = "Publisher Copyright: {\textcopyright} The Royal Australian and New Zealand College of Psychiatrists 2018.",

year = "2018",

month = aug,

day = "1",

doi = "10.1177/1039856218766120",

language = "English",

volume = "26",

pages = "376--380",

journal = "Australasian Psychiatry",

issn = "1039-8562",

publisher = "SAGE Publications",

number = "4",

}

TY - JOUR

T1 - Huntington’s disease

T2 - Managing neuropsychiatric symptoms in Huntington’s disease

AU - Loi, Samantha M.

AU - Walterfang, Mark

AU - Velakoulis, Dennis

AU - Looi, Jeffrey C.L.

N1 - Publisher Copyright: © The Royal Australian and New Zealand College of Psychiatrists 2018.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Objectives: This clinical update review focuses on the management of the neuropsychiatric manifestations of Huntington’s disease (HD). The review highlights current issues regarding pharmacological and non-pharmacological treatment, putative therapeutics and recent relevant research findings in this area. Conclusions: Neuropsychiatric symptoms may precede the classic motor clinical symptoms of HD (prodromal HD) by decades and cause significant functional impairment. Early recognition and comprehensive non-pharmacological, usually in combination with pharmacological, treatment is essential.

AB - Objectives: This clinical update review focuses on the management of the neuropsychiatric manifestations of Huntington’s disease (HD). The review highlights current issues regarding pharmacological and non-pharmacological treatment, putative therapeutics and recent relevant research findings in this area. Conclusions: Neuropsychiatric symptoms may precede the classic motor clinical symptoms of HD (prodromal HD) by decades and cause significant functional impairment. Early recognition and comprehensive non-pharmacological, usually in combination with pharmacological, treatment is essential.

KW - huntington’s disease

KW - neuropsychiatric symptoms

KW - psychiatry

UR - http://www.scopus.com/inward/record.url?scp=85046809643&partnerID=8YFLogxK

U2 - 10.1177/1039856218766120

DO - 10.1177/1039856218766120

M3 - Article

SN - 1039-8562

VL - 26

SP - 376

EP - 380

JO - Australasian Psychiatry

JF - Australasian Psychiatry

IS - 4

ER -

Huntington’s disease: Managing neuropsychiatric symptoms in Huntington’s disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this